BHVN
Price
$16.21
Change
+$0.32 (+2.01%)
Updated
Sep 3 closing price
Capitalization
1.71B
75 days until earnings call
CRNX
Price
$34.65
Change
+$1.35 (+4.05%)
Updated
Sep 3 closing price
Capitalization
3.27B
63 days until earnings call
Interact to see
Advertisement

BHVN vs CRNX

Header iconBHVN vs CRNX Comparison
Open Charts BHVN vs CRNXBanner chart's image
Biohaven
Price$16.21
Change+$0.32 (+2.01%)
Volume$2.43M
Capitalization1.71B
Crinetics Pharmaceuticals
Price$34.65
Change+$1.35 (+4.05%)
Volume$1.77M
Capitalization3.27B
BHVN vs CRNX Comparison Chart in %
Loading...
BHVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BHVN vs. CRNX commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHVN is a StrongBuy and CRNX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (BHVN: $16.21 vs. CRNX: $34.65)
Brand notoriety: BHVN and CRNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BHVN: 126% vs. CRNX: 197%
Market capitalization -- BHVN: $1.71B vs. CRNX: $3.27B
BHVN [@Biotechnology] is valued at $1.71B. CRNX’s [@Biotechnology] market capitalization is $3.27B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BHVN’s FA Score shows that 0 FA rating(s) are green whileCRNX’s FA Score has 0 green FA rating(s).

  • BHVN’s FA Score: 0 green, 5 red.
  • CRNX’s FA Score: 0 green, 5 red.
According to our system of comparison, both BHVN and CRNX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BHVN’s TA Score shows that 6 TA indicator(s) are bullish while CRNX’s TA Score has 5 bullish TA indicator(s).

  • BHVN’s TA Score: 6 bullish, 3 bearish.
  • CRNX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, BHVN is a better buy in the short-term than CRNX.

Price Growth

BHVN (@Biotechnology) experienced а +3.91% price change this week, while CRNX (@Biotechnology) price change was +13.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.29%. For the same industry, the average monthly price growth was +15.06%, and the average quarterly price growth was +30.89%.

Reported Earning Dates

BHVN is expected to report earnings on Nov 18, 2025.

CRNX is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+0.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($3.27B) has a higher market cap than BHVN($1.72B). CRNX YTD gains are higher at: -32.232 vs. BHVN (-56.600). CRNX has higher annual earnings (EBITDA): -419.62M vs. BHVN (-792.68M). CRNX has more cash in the bank: 1.2B vs. BHVN (405M). CRNX has less debt than BHVN: CRNX (49.9M) vs BHVN (292M). CRNX has higher revenues than BHVN: CRNX (1.39M) vs BHVN (0).
BHVNCRNXBHVN / CRNX
Capitalization1.72B3.27B52%
EBITDA-792.68M-419.62M189%
Gain YTD-56.600-32.232176%
P/E RatioN/AN/A-
Revenue01.39M-
Total Cash405M1.2B34%
Total Debt292M49.9M585%
FUNDAMENTALS RATINGS
BHVN vs CRNX: Fundamental Ratings
BHVN
CRNX
OUTLOOK RATING
1..100
7317
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
89
Overvalued
PROFIT vs RISK RATING
1..100
10062
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
6453
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BHVN's Valuation (65) in the Pharmaceuticals Major industry is in the same range as CRNX (89). This means that BHVN’s stock grew similarly to CRNX’s over the last 12 months.

CRNX's Profit vs Risk Rating (62) in the Pharmaceuticals Major industry is somewhat better than the same rating for BHVN (100). This means that CRNX’s stock grew somewhat faster than BHVN’s over the last 12 months.

CRNX's SMR Rating (97) in the Pharmaceuticals Major industry is in the same range as BHVN (100). This means that CRNX’s stock grew similarly to BHVN’s over the last 12 months.

CRNX's Price Growth Rating (53) in the Pharmaceuticals Major industry is in the same range as BHVN (64). This means that CRNX’s stock grew similarly to BHVN’s over the last 12 months.

CRNX's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as BHVN (100). This means that CRNX’s stock grew similarly to BHVN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BHVNCRNX
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
78%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
75%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
76%
Declines
ODDS (%)
Bearish Trend 7 days ago
76%
Bearish Trend 16 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
74%
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
BHVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRUIX169.910.86
+0.51%
T. Rowe Price Equity Index 500 I
BGLKX39.040.14
+0.36%
Baillie Gifford Long Term Global Gr K
TARZX26.170.09
+0.35%
Third Avenue Real Estate Value Z
AGCSX20.92-0.03
-0.14%
American Century Global Small Cap I
FKAIX53.27-0.14
-0.26%
Federated Hermes Kaufmann Small Cap IS

BHVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BHVN has been loosely correlated with SYRE. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if BHVN jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHVN
1D Price
Change %
BHVN100%
+2.01%
SYRE - BHVN
52%
Loosely correlated
+1.08%
CGON - BHVN
50%
Loosely correlated
+4.41%
BEAM - BHVN
49%
Loosely correlated
+15.02%
CRNX - BHVN
48%
Loosely correlated
+4.05%
RVMD - BHVN
46%
Loosely correlated
+0.61%
More

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with XNCR. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
+4.05%
XNCR - CRNX
62%
Loosely correlated
-2.57%
RVMD - CRNX
58%
Loosely correlated
+0.61%
IDYA - CRNX
58%
Loosely correlated
+1.10%
NRIX - CRNX
56%
Loosely correlated
+3.84%
SYRE - CRNX
56%
Loosely correlated
+1.08%
More